technology transfer

Summary

Summary: Spread and adoption of inventions and techniques from one geographic area to another, from one discipline to another, or from one sector of the economy to another. For example, improvements in medical equipment may be transferred from industrial countries to developing countries, advances arising from aerospace engineering may be applied to equipment for persons with disabilities, and innovations in science arising from government research are made available to private enterprise.

Top Publications

  1. ncbi Transfusion medicine technology transfer: traps to avoid
    Philip Mendes
    Technology Law, Brisbane, Australia
    Transfus Med Rev 16:25-33. 2002
  2. ncbi Data-sharing and data-withholding in genetics and the life sciences: results of a national survey of technology transfer officers
    Eric G Campbell
    Harvard Medical School, Boston, MA, USA
    J Health Care Law Policy 6:241-55. 2003
  3. pmc HIV prevention technology transfer: challenges and strategies in the real world
    Rosemary C Veniegas
    Center for HIV Identification, Prevention, and Treatment Services, University of California, Los Angeles, CA 90024, USA
    Am J Public Health 99:S124-30. 2009
  4. ncbi Replicating effective programs: HIV/AIDS prevention technology transfer
    M S Neumann
    Division of HIV AIDS Prevention Intervention Research and Support, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Educ Prev 12:35-48. 2000
  5. ncbi Translational and clinical science--time for a new vision
    Elias A Zerhouni
    National Institutes of Health, USA
    N Engl J Med 353:1621-3. 2005
  6. ncbi Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV
    Wilfried A M Bakker
    National Institute for Public Health and the Environment, Vaccinology Unit, P O Box 1, 3720BA Bilthoven, The Netherlands
    Vaccine 29:7188-96. 2011
  7. pmc International technology transfer of a GCLP-compliant HIV-1 neutralizing antibody assay for human clinical trials
    Daniel A Ozaki
    Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America
    PLoS ONE 7:e30963. 2012
  8. pmc Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR
    L Dyrskjøt
    Department of Molecular Medicine, Aarhus University Hospital, Skejby, Denmark
    Br J Cancer 107:1392-8. 2012
  9. ncbi The global access initiative at the University of British Columbia (UBC): Availability of UBC discoveries and technologies to the developing world
    Kishor M Wasan
    The University of British Columbia, Faculty of Pharmaceutical Sciences, Division of Pharmaceutics and Biopharmaceutics, 2146 East Mall, Vancouver, B C, Canada V6T 123
    J Pharm Sci 98:791-4. 2009
  10. ncbi Inside the triple helix: technology transfer and commercialization in the life sciences
    Eric G Campbell
    Harvard Medical School, USA
    Health Aff (Millwood) 23:64-76. 2004

Detail Information

Publications193 found, 100 shown here

  1. ncbi Transfusion medicine technology transfer: traps to avoid
    Philip Mendes
    Technology Law, Brisbane, Australia
    Transfus Med Rev 16:25-33. 2002
    b>Technology transfer is the process of commercializing technology and taking it from the laboratory to the marketplace. At some stage in the technology transfer process, a due diligence will be undertaken...
  2. ncbi Data-sharing and data-withholding in genetics and the life sciences: results of a national survey of technology transfer officers
    Eric G Campbell
    Harvard Medical School, Boston, MA, USA
    J Health Care Law Policy 6:241-55. 2003
  3. pmc HIV prevention technology transfer: challenges and strategies in the real world
    Rosemary C Veniegas
    Center for HIV Identification, Prevention, and Treatment Services, University of California, Los Angeles, CA 90024, USA
    Am J Public Health 99:S124-30. 2009
    ..We examined implementation of evidence-based interventions for HIV prevention at community-based organizations in Los Angeles County, CA...
  4. ncbi Replicating effective programs: HIV/AIDS prevention technology transfer
    M S Neumann
    Division of HIV AIDS Prevention Intervention Research and Support, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Educ Prev 12:35-48. 2000
    ..The experience of the REP project indicates that technology transfer is complex. Interventions need to be adapted to local circumstances...
  5. ncbi Translational and clinical science--time for a new vision
    Elias A Zerhouni
    National Institutes of Health, USA
    N Engl J Med 353:1621-3. 2005
  6. ncbi Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV
    Wilfried A M Bakker
    National Institute for Public Health and the Environment, Vaccinology Unit, P O Box 1, 3720BA Bilthoven, The Netherlands
    Vaccine 29:7188-96. 2011
    ..Also, results will be shown from large-scale (to prepare for future technology transfer) generation of Master- and Working virus seedlots, and clinical trial material (for phase I studies) ..
  7. pmc International technology transfer of a GCLP-compliant HIV-1 neutralizing antibody assay for human clinical trials
    Daniel A Ozaki
    Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America
    PLoS ONE 7:e30963. 2012
    ..As a result, several of the CAVD/CA-VIMC Regional Laboratories are now in the process of conducting or planning to conduct the GCLP-compliant TZM-bl NAb Assay as an indicator of vaccine immunogenicity for ongoing human clinical trials...
  8. pmc Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR
    L Dyrskjøt
    Department of Molecular Medicine, Aarhus University Hospital, Skejby, Denmark
    Br J Cancer 107:1392-8. 2012
    ....
  9. ncbi The global access initiative at the University of British Columbia (UBC): Availability of UBC discoveries and technologies to the developing world
    Kishor M Wasan
    The University of British Columbia, Faculty of Pharmaceutical Sciences, Division of Pharmaceutics and Biopharmaceutics, 2146 East Mall, Vancouver, B C, Canada V6T 123
    J Pharm Sci 98:791-4. 2009
    ..This commentary will discuss these principles and provide examples of where they have been applied to several UBC technologies...
  10. ncbi Inside the triple helix: technology transfer and commercialization in the life sciences
    Eric G Campbell
    Harvard Medical School, USA
    Health Aff (Millwood) 23:64-76. 2004
    ..bias in the reporting of results, limited revenues from these activities, and the lack of data to evaluate technology transfer activities...
  11. ncbi The cost-effectiveness of technology transfer using telemedicine
    K Johnston
    Health Economics Research Centre, University of Oxford, UK
    Health Policy Plan 19:302-9. 2004
    ..b>Technology transfer is one way to improve specialist skills whilst at the same time reducing the burden of disease...
  12. ncbi Technology transfer of Sabin-IPV to new developing country markets
    Hans Kreeftenberg
    Netherlands Vaccine Institute NVI, Antonie van Leeuwenhoeklaan 11, 3720 AL Bilthoven, The Netherlands
    Biologicals 34:155-8. 2006
    ..This paper discusses the approach followed and the experience already gained in the project, as well as factors critical to its success...
  13. ncbi Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant protein
    Mairead Looby
    Pfizer Ireland Pharmaceuticals, Grange Castle International Business Park, Dublin 22, Ireland
    Biotechnol Prog 27:1718-29. 2011
    ....
  14. pmc Auto-disable syringes for immunization: issues in technology transfer
    J S Lloyd
    World Health Organization, Geneva, Switzerland
    Bull World Health Organ 77:1001-7. 1999
    ..The present article examines factors influencing technology transfer, including feasibility, corporate interest, cost, quality assurance, intellectual property considerations, ..
  15. ncbi Accomplishing technology transfer: case-based lessons of what works and what does not
    Joseph P Lane
    Rehabilitation Research and Training Center on Technology Transfer, University at Buffalo, Buffalo, New York 14214, USA
    Assist Technol 15:69-88. 2003
    This paper presents lessons drawn from technology transfer case studies that address the persistent question: "What works, what does not, and why?" Each lesson highlights critical factors determining success or failure and is ..
  16. ncbi Health innovation networks to help developing countries address neglected diseases
    Carlos M Morel
    Center for Technological Development in Health, Oswaldo Cruz Foundation FIOCRUZ, Avenida Brasil 4365, Rio de Janeiro, RJ 21040 900, Brazil
    Science 309:401-4. 2005
    ..Here we highlight a complementary and increasingly important means to improve health equity: the growing ability of some developing countries to undertake health innovation...
  17. ncbi WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer
    Martin Friede
    World Health Organization, Avenue Appia, 1211 Geneva, Switzerland
    Vaccine 29:A2-7. 2011
    ..g. those that allow significant dose-sparing. To this end, the influenza vaccine technology transfer initiative was launched in 2007 and, to date, vaccine manufacturers in 11 developing countries have ..
  18. pmc Technology transfer from worms and flies to vertebrates: transposition-based genome manipulations and their future perspectives
    Lajos Mátés
    Max Delbruck Center for Molecular Medicine, Robert Rössle Str, 13092 Berlin, Germany
    Genome Biol 8:S1. 2007
    ....
  19. pmc Information technology in complex health services: organizational impediments to successful technology transfer and diffusion
    F C Southon
    Fujitsu Centre, University of New South Wales, Caringbah, Australia
    J Am Med Inform Assoc 4:112-24. 1997
    ..To identify impediments to the successful transfer and implementation of packaged information systems through large, divisionalized health services...
  20. ncbi Technology transfer pathways and livelihood impact indicators in central Ethiopia
    A Tesfaye
    Holetta Research Center, Addis Ababa Ethiopia 4 Villardi Consulting, Singapore Correspondence E mail com sg
    Trop Anim Health Prod 37:101-22. 2005
    ..The results showed that there are many opportunities for group dissemination by making use of existing social networks. There are also opportunities for dissemination through extension agents, farmer groups and radio broadcasting...
  21. ncbi Technology transfer through performance management: the effects of graphical feedback and positive reinforcement on drug treatment counselors' behavior
    M E Andrzejewski
    Department of Psychology, Temple University, Weiss Hall 265 66, Philadelphia, PA 19122, USA
    Drug Alcohol Depend 63:179-86. 2001
    ..Nonetheless, present results show promise that feedback and positive reinforcement could be used to improve technology transfer of behavioral interventions into community clinic settings.
  22. ncbi Can patents deter innovation? The anticommons in biomedical research
    M A Heller
    University of Michigan Law School, Ann Arbor, MI 48109 1215, USA
    Science 280:698-701. 1998
    ..Otherwise, more intellectual property rights may lead paradoxically to fewer useful products for improving human health...
  23. doi Translational research: a case history
    Helen Pearson
    Nature 453:846-9. 2008
  24. ncbi Technology transfer: U.S. scientists faulted on biotech consulting
    Jocelyn Kaiser
    Science 304:1222. 2004
  25. ncbi Training substance abuse treatment organizations to adopt evidence-based practices: the Addiction Technology Transfer Center of New England Science to Service Laboratory
    Daniel D Squires
    Addiction Technology Transfer Center of New England and Brown University Center for Alcohol and Addiction Studies, Brown University, Providence, RI 02912, USA
    J Subst Abuse Treat 34:293-301. 2008
    ..To help address this gap, the Addiction Technology Transfer Center of New England (ATTC-NE), located at Brown University, has adapted and implemented an organizational ..
  26. ncbi Technology transfer from the science of medicine to the real world: the potential role played by artificial adaptive systems
    Enzo Grossi
    Bracco SpA, Milan, Italy
    Subst Use Misuse 42:267-304. 2007
    ..These tools can allow a more efficient technology transfer from the science of medicine to the real world, overcoming many obstacles responsible for the present ..
  27. ncbi Challenges and opportunities for enhancing biotechnology and technology transfer in developing countries
    Luis A Salicrup
    Office of the Director Office of Technology Transfer, National Institutes of Health, Department of Health and Human Services, Rockville, MD 20852, USA
    Biotechnol Adv 24:69-79. 2006
    ..The challenge, however, lies in defining the role of technology transfer to develop therapies for diseases prevalent in developing countries...
  28. ncbi Research translation: a new frontier for clinical laboratories
    Mario Plebani
    Department of Laboratory Medicine, University Hospital of Padova, and Center of Biomedical Research, Castelfranco Veneto TV, Italy
    Clin Chem Lab Med 44:1303-12. 2006
    ....
  29. ncbi A discussion of the concept of technology transfer of research-based drug "abuse" prevention and treatment interventions
    Zili Sloboda
    Institute for Health and Social Policy, The University of Akron, Ohio, USA
    Subst Use Misuse 37:1079-87. 2002
    ..Several theoretical perspectives that have not been brought into the technology transfer discussion are mentioned, others need to be reviewed for their potential to guide further research in this ..
  30. ncbi Role and reality: technology transfer at Canadian universities
    Tania M Bubela
    School of Public Health, Department of Public Health Sciences, 3030 Research Transition Facility, University of Alberta, Edmonton, Alberta, Canada
    Trends Biotechnol 28:447-51. 2010
    b>Technology transfer offices (TTOs) play a central role in the knowledge translation and commercialization agenda of Canadian universities...
  31. ncbi The federal role in drug abuse technology transfer: a history and perspective
    Barry S Brown
    University of North Carolina at Wilmington, Wilmington, NC 28403, USA
    J Subst Abuse Treat 22:245-57. 2002
    ..more effective in achieving the individual and organizational behavior change needed to achieve technology transfer. Argument is made that the federal government remains the best, if not the only resource for promoting ..
  32. pmc Agency context and tailored training in technology transfer: a pilot evaluation of motivational interviewing training for community counselors
    John S Baer
    Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA, USA
    J Subst Abuse Treat 37:191-202. 2009
    ....
  33. ncbi University-based science and biotechnology products: defining the boundaries of intellectual property
    Aaron S Kesselheim
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02120, USA
    JAMA 293:850-4. 2005
    ....
  34. ncbi Influenza vaccine production for Brazil: a classic example of successful North-South bilateral technology transfer
    Cosue Miyaki
    BioIndustrial Division, Influenza Production Laboratory, Instituto Fundação Butantan, Sao Paulo, Brazil
    Vaccine 29:A12-5. 2011
    b>Technology transfer is a promising approach to increase vaccine production at an affordable price in developing countries...
  35. ncbi A technology transfer model for effective HIV/AIDS interventions: science and practice
    J M Kraft
    Division of HIV AIDS Prevention Intervention Research and Support, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    AIDS Educ Prev 12:7-20. 2000
    ..Starting with a review of diffusion of innovations and technology transfer literature, we offer a technology transfer model for HIV interventions...
  36. ncbi Partnerships in technology transfer. An innovative program to enhance biomedical research and global health
    Luis A Salicrup
    Int Microbiol 8:1-3. 2005
  37. ncbi Sustainable transfer of biotechnology to developing countries: fighting poverty by bringing scientific tools to developing-country partners
    Josefina Coloma
    Division of Infectious Diseases, School of Public Health, University of California, Berkeley, 1 Barker Hall 422, Berkeley, CA 94720 7354, USA
    Ann N Y Acad Sci 1136:358-68. 2008
    ..For 20 years, the Sustainable Sciences Institute has built scientific capacity in developing countries to recognize, prevent, and respond to the threats posed by disease...
  38. ncbi A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exception
    David C Hoffman
    Cornell Law Rev 89:993-1043. 2004
  39. ncbi The CREATE Act: increasing costs associated with the biotech industry?
    Ann E Mills
    Program in Ethics and Policy in Health Care, Center for Biomedical Ethics, University of Virginia School of Medicine, P O Box 800758, Charlottesville, Virginia 22908, USA
    Nat Biotechnol 24:785-6. 2006
    ..A new law intended to promote collaborative research may end up costing the biotech industry more and inhibiting innovation...
  40. ncbi [Malignant lymphoma competence network]
    A Herrmann-Frank
    Kompetenznetz Maligne Lymphome, Zentrale Klinikum der Universität zu Köln
    Internist (Berl) 45:429-35. 2004
    ..Further information is presented in http://www.lymphome.de...
  41. ncbi Applications of optical coherence tomography to cardiac and musculoskeletal diseases: bench to bedside?
    Mark E Brezinski
    Brigham and Women s Hospital, Department of Orthopedic Surgery, 75 Francis Street and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Biomed Opt 12:051705. 2007
    ....
  42. ncbi Found in translation; from the laboratory to the operating room to the market
    Robert L Galloway
    Biomedical Engineering, Neurological Surgery, and Center for Technology Guided Therapy, Vanderbilt University, Nashville, TN, USA
    Conf Proc IEEE Eng Med Biol Soc 2007:5162-5. 2007
    ..We have faced each of the above defined translation challenges and more remain. The presentation (and paper) will cover the process of achieving that success and of lessons often painfully learned...
  43. ncbi [Competence network "community acquired pneumonia" (CAPNETZ). A first interim report]
    T Welte
    Abteilung für Pneumologie und Intensivmedizin, Universitatsklinikum Magdeburg
    Internist (Berl) 45:393-401. 2004
    ..First results indicate, that new observations made in terms of symptoms, spectrum of pathogens involved, and treatment modalities will impact on the formulation of new guidelines for the management of community acquired pneumonia...
  44. ncbi Biotechnology products and university-based science
    Gregory K Sobolski
    JAMA 293:2862; author reply 2863. 2005
  45. ncbi [Sharing of biotechnology: contractual agreements as avant-garde]
    Christine Noiville
    CNRS Université Paris I Panthéon Sorbonne, Centre de recherche en droit des sciences et techniques, France
    Med Sci (Paris) 21:998-1001. 2005
    ....
  46. ncbi Biotechnology products and university-based science
    Philip Lempert
    JAMA 293:2861-2; author reply 2863. 2005
  47. ncbi Intellectual property and biotechnology: the U.S. internal experience--Part I
    Baruch Brody
    Center for Medical Ethics, Baylor College of Medicine, Houston, TX, USA
    Kennedy Inst Ethics J 16:1-37. 2006
    ..Despite these hesitations, the U.S. rejected suggested modifications. This was a mistake, and there is a need to develop a modified system that promotes more of the relevant ethical values...
  48. ncbi Tech transfer fails to translate into startups
    Stacy Lawrence
    Nat Biotechnol 25:616. 2007
  49. ncbi Tech transfer revs up
    Stacy Lawrence
    Nat Biotechnol 24:13. 2006
  50. ncbi Bioengineering and translational research
    Yongmin Kim
    IEEE Eng Med Biol Mag 24:5. 2005
  51. ncbi The university-promoted patent at the crossroads of the research results and immediate industrial use
    R Doddoli
    BIOFUTURE Research Consortium in Regenerative Medicine, c o Department of Chemistry, University of Bari, Italy
    Biomol Eng 24:43-6. 2007
    ..For the latter, owing to their nature, demand that there be no wastage and cautious management thereof...
  52. ncbi Beyond Bayh-Dole and the Lambert Review: an initial product development and transaction model for the interface between universities and business
    Michael Fernandes
    Medbase LLC, 94 Gallup Road, Princeton, NJ 08540, USA
    Biotechnol Genet Eng Rev 21:249-76. 2004
  53. ncbi Biotechnology products and university-based science
    David Korn
    JAMA 293:2862-3; author reply 2863. 2005
  54. ncbi NIH licensing performance under par
    Ken Garber
    Nat Biotechnol 22:1607-8. 2004
  55. ncbi Intellectual property and biotechnology: the U.S. internal experience--Part II
    Baruch Brody
    Center for Medical Ethics, Baylor College of Medicine, Houston, TX, USA
    Kennedy Inst Ethics J 16:105-28. 2006
    ..In each of these cases, the modifications might be more responsive to the full set of relevant values...
  56. ncbi Technology transfer across industries
    David Woodley
    Technograph Microcircuits Ltd, Portsmouth, UK
    Med Device Technol 15:18-21. 2004
    ..Although these are typically outside the core competence of most medical product developers, partnering with a specialist manufacturer can offer rapid access...
  57. ncbi Technology transfer: seeking a more efficient way
    J M Wilkinson
    Technology for Industry Ltd, Ely, UK
    Med Device Technol 17:36, 38-9. 2006
    ..A wide cultural gap persists between the two and an effective means of partnering is required. This review looks at current solutions and recent progress...
  58. ncbi Cluster formation as a tool for development in Medicon Valley
    Stina Gestrelius
    Medicon Valley Academy, Orestad City, Copenhagen S, Denmark
    IEEE Eng Med Biol Mag 25:102-5. 2006
  59. ncbi Innovation and the medical devices Farady partnership
    M Tavakoli
    Medical Devices Faraday Partnership, TWI Ltd, Great Abington, Cambridge, UK
    Med Device Technol 16:32-5. 2005
    ..The services it offers medical device manufacturers are outlined here...
  60. ncbi [Systemic inflammatory rheumatic diseases competence network]
    C Rufenach
    Geschäftsführerin im Kompetenznetz Rheuma, Deutsches Rheumaforschungszentrum Berlin
    Internist (Berl) 45:409-14. 2004
    ..The primary objective of this collaboration is to transfer new scientific insights more rapidly in order to improve methods for diagnosis and patients treatment...
  61. ncbi Value creation and sharing among universities, biotechnology and pharma
    Mark G Edwards
    Recombinant Capital, 2033 N Main St, Walnut Creek, CA 94596, USA
    Nat Biotechnol 21:618-24. 2003
  62. doi Harvard turns to matchmaking to speed translational research
    Meredith Wadman
    Nat Med 14:697. 2008
  63. doi University research. Steering Harvard toward collaborative science
    Andrew Lawler
    Science 321:190-2. 2008
  64. ncbi Science and the law. Working through the patent problem
    John P Walsh
    Department of Sociology, University of Illinois at Chicago, Chicago, IL 60607 7140, USA
    Science 299:1021. 2003
  65. ncbi CASH 2021: commercial access and space habitation
    Andrew Aldrin
    Students of the International Space University Summer Session Program 2001, Bremen, Germany
    Acta Astronaut 51:637-46. 2002
    ..A broad range of commercially viable opportunities, not only within the current limits of the International Space Station, but also among the many new developments that are expected by 2021 are discussed...
  66. ncbi The changing norms of the life sciences
    Peter Shorett
    Council for Responsible Genetics, Cambridge, MA 02140, USA
    Nat Biotechnol 21:123-5. 2003
  67. ncbi Historical essay. Prospects for the future
    Robert C Gallo
    Institute of Human Virology and Department of Microbiology and Immunology, University of Maryland, Baltimore, MD 21201, USA
    Science 298:1730-1. 2002
  68. ncbi Genomics and global health: time for a reappraisal
    David J Weatherall
    Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford, OX3 9DS, UK
    Science 302:597-9. 2003
    ....
  69. ncbi The rice genome. World poverty and hunger--the challenge for science
    Ismail Serageldin
    Library of Alexandria, Bibliotheca Alexandrina, Shatby, Alexandria 21526, Egypt
    Science 296:54-8. 2002
  70. ncbi The rice genome. The cereal of the world's poor takes center stage
    Ronald P Cantrell
    International Rice Research Institute IRRI, DAPO Box 7777, Metro Manila, Philippines
    Science 296:53. 2002
  71. ncbi South Korea. Institute helps spread use of vaccines in Asia
    Mark Russell
    Science 295:611-2. 2002
  72. ncbi Medical innovation and institutional interdependence: rethinking university-industry connections
    Annetine C Gelijns
    College of Physicians and Surgeons and School of Public Health, Columbia University, 600 W 168th St, Seventh Floor, New York, NY 10032, USA
    JAMA 287:72-7. 2002
    ..medical innovation depends on extensive interactions between universities and industry, with knowledge and technology transfer flowing in both directions. These interactions have had important public health and economic benefits...
  73. ncbi Protecting rights to early-stage technology
    Michael J Shuster
    Fenwick and West LLP, 275 Battery Street, San Francisco, CA 94111, USA
    Nat Biotechnol 21:701-3. 2003
  74. pmc Knowledge systems for sustainable development
    David W Cash
    John F Kennedy School of Government, Harvard University, 79 John F Kennedy Street, Cambridge, MA 02138, USA
    Proc Natl Acad Sci U S A 100:8086-91. 2003
    ..Effective systems apply a variety of institutional mechanisms that facilitate communication, translation and mediation across boundaries...
  75. ncbi [Chronic inflammatory bowel diseases competence network ]
    U R Folsch
    1 Medizinische Universitätsklinik, Klinikum der Christian Albrechts Universität Kiel
    Internist (Berl) 45:402-8. 2004
    ....
  76. ncbi [HIV/AIDS competence network research group presents first results]
    N H Brockmeyer
    Sprecher des Kompetenznetz HIV AIDS, Klinik für Dermatologie und Allergologie, Ruhr Universitat Bochum
    Internist (Berl) 45:422-8. 2004
    ..The establishment of a patient cohort is linked to 20 projects. The success of this new structure is becoming visible...
  77. ncbi [Hepatitis (Hep-Net) competence network]
    H Wedemeyer
    Kompetenznetz Hepatitis, c o Medizinische Hochschule Hannover
    Internist (Berl) 45:415-21. 2004
    ..Further, basic questions in the fields of epidemiology, virology and immunology are processed in cooperative research projects within the network...
  78. ncbi A US perspective on technology transfer: the changing role of the university
    Lita L Nelsen
    Technology Licensing Office, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139 4307, USA
    Nat Rev Mol Cell Biol 5:243-7. 2004
  79. pmc Lowering the barriers inherent in translating advances in neuroimage analysis to clinical research applications
    Sonia Pujol
    Harvard Medical School, Department of Radiology, L1 050, Brigham and Women s Hospital, 75 Francis Street, Boston MA 02115, USA
    Acad Radiol 15:114-8. 2008
    ....
  80. ncbi Invention and business performance in the tissue-engineering industry
    Nitin Pangarkar
    School of Business, Faculty of Engineering, National University of Singapore, Singapore
    Tissue Eng 9:1313-22. 2003
    ..We also argue that, to achieve commercial success, firms need to manage time to market (through alliances or otherwise), have a global outlook, nurture their financial resources, and attain critical mass through mergers...
  81. ncbi Information transfer from the USA and Europe to Latin America: current need and suitable methods
    Anneliese Fischer Thom
    Eur J Nucl Med Mol Imaging 30:1073-5. 2003
  82. ncbi Biotechnology and sustainability: the role of transatlantic cooperation in research and innovation
    Alfredo Aguilar
    Head of Unit Biotechnologies, Research Directorate General, European Commission, Brussels, Belgium
    Trends Biotechnol 26:163-5. 2008
    ....
  83. ncbi Commercializing nanotechnology
    Laura Mazzola
    Excellin Life Sciences, 755 East Capitol Avenue 0201, Milpitas, California 95035, USA
    Nat Biotechnol 21:1137-43. 2003
  84. doi China steps up US biotech intellectual property land grab
    Mark Ratner
    Nat Biotechnol 26:141-2. 2008
  85. ncbi The international translational regenerative medicine center
    Mardi de Veuve Alexis
    International Translational Regenerative Medicine Center, Beckman Research Institute at City of Hope, CA, USA
    Regen Med 7:74-5. 2012
    ....
  86. ncbi Lessons learned from the Apple stores
    Henry Pinkney
    J Med Pract Manage 27:307-8. 2012
    ..This article will discuss the services provided by Apple, Inc., and how medical practices can learn from this industry giant and improve the services that they offer patients...
  87. pmc Informatics technology mimics ecology: dense, mutualistic collaboration networks are associated with higher publication rates
    MARCO D SORANI
    Department of Neurological Surgery, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 7:e30463. 2012
    ..There are rapidly changing trends in external technological and macroeconomic influences. We propose that a better understanding of how technologies are adopted can facilitate their development...
  88. pmc A critical view of current state of phytotechnologies to remediate soils: still a promising tool?
    Héctor M Conesa
    Departamento de Ciencia y Tecnología Agraria, Universidad Politecnica de Cartagena, Paseo Alfonso XIII, 48 30203 Cartagena, Spain
    ScientificWorldJournal 2012:173829. 2012
    ..Valuable biomass includes timber, bioenergy, feedstock for pyrolosis, biofortified products, or ecologically important species...
  89. pmc Health research systems: promoting health equity or economic competitiveness?
    Bridget Pratt
    Michael Kirby Centre for Public Health and Human Rights, Monash University, Alfred Centre Campus, 99 Commercial Road, Melbourne, Vic, 3004, Australia
    Bull World Health Organ 90:55-62. 2012
    ..e. health policy and systems research. Governments must restructure their research laws and policies to increase this essential research in developing countries...
  90. ncbi Universities urged to do more for poor nations
    Erika Check
    Nature 444:412-3. 2006
  91. pmc Systems biology driven software design for the research enterprise
    John Boyle
    Institute for Systems Biology, 1441 N 34th Street, Seattle, WA 98103, USA
    BMC Bioinformatics 9:295. 2008
    ..As scientists work in isolated groups, integration with other groups is rarely a consideration when building the required software tools...
  92. ncbi Cultural innovations and demographic change
    Peter J Richerson
    Department of Environmental Science and Policy, University of California Davis, Davis, CA 95616, USA
    Hum Biol 81:211-35. 2009
    ....
  93. ncbi Those to change, those never to change
    Eiji Kanehira
    Minim Invasive Ther Allied Technol 16:139-40. 2007
  94. ncbi Concepts and tools to exploit the potential of bacterial inclusion bodies in protein science and biotechnology
    Pietro Gatti-Lafranconi
    Department of Biochemistry, University of Cambridge, Cambridge, UK
    FEBS J 278:2408-18. 2011
    ..We also review the major biophysical methods available for revealing fine structural details of aggregated proteins and which information can be obtained through these techniques...
  95. ncbi Relationships with industry: critical for new technology or an unnecessary evil?
    Joshua J Jacobs
    Rush University Medical Center, Chicago, IL 60612, USA
    J Bone Joint Surg Am 88:1650-63. 2006
  96. ncbi Current trends in antimicrobial agent research: chemo- and bioinformatics approaches
    Riadh Hammami
    STELA Dairy Research Center, Nutraceuticals and Functional Foods Institute, Universite Laval, Quebec, QC, Canada
    Drug Discov Today 15:540-6. 2010
    ..This article reviews progress in the development of computational methods, tools and databases used for organizing and extracting biological meaning from antimicrobial research...
  97. ncbi Clinical peptidomic analysis by a one-step direct transfer technology: its potential utility for monitoring of pathophysiological status in female reproductive system disorders
    Yoshihiko Araki
    Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan Department of Obstetrics and Gynecology, Juntendo University Graduate School of Medicine, Tokyo, Japan
    J Obstet Gynaecol Res 39:1440-8. 2013
    ..In addition, we refer to the potential utility of this approach for the monitoring of pathophysiological status in female reproductive system disorders in general. ..
  98. ncbi University spin-offs: opportunity or challenge?
    Xiaogang Peng
    Department of Chemistry and Biochemistry, University of Arkansas, 348 Arkansas Avenue, Fayetteville, Arkansas 72701, USA
    Nat Mater 5:923-5. 2006
  99. ncbi The genome projects: implications for dental practice and education
    J T Wright
    Department of Pediatric Dentistry, School of Dentistry, University of North Carolina, Chapel Hill 27599, USA
    J Dent Educ 66:659-71. 2002
    ..Oral health care practitioners will increasingly require knowledge of human genetics and the application of new molecular-based diagnostic and therapeutic technologies...
  100. ncbi [Consequence of intellectual property and consortium project in neurosurgery]
    Osamu Honmou
    Department of Neurosurgery, Sapporo Medical University School of Medicine, Japan
    No Shinkei Geka 32:571-7. 2004
  101. ncbi Thoracic sonography for pneumothorax: the clinical evaluation of an operational space medicine spin-off
    Andrew W Kirkpatrick
    Foothills Medical Centre, Calgary, Alberta, Canada Andrew
    Acta Astronaut 56:831-8. 2005
    ..Applied thoracic US is an example of a clinically useful space medicine spin-off that is improving health care on earth...

Research Grants65

  1. PROMOTING TRANSLATIONAL DENTAL RESEARCH ACADEMIC CAREERS
    EDWARD ROSSOMANDO; Fiscal Year: 2008
    ..research are only partially offered through these awards, and education in entrepreneurship, management and technology transfer are not specifically provided...
  2. Workshop Course to Promote and Develop Dental Technology
    EDWARD ROSSOMANDO; Fiscal Year: 2004
    ..recommendation concerning the development of competency in research management, entrepreneurship and the technology transfer process...
  3. Brief Family-Based Therapy for Adolescent Drug Abuse
    Howard Liddle; Fiscal Year: 2004
    ..The study could produce one of the first brief, family-based therapies for adolescent drug abusers and yield findings that would have significant implications for technology transfer efforts.
  4. Training Strategies for Motivational Interviewing
    Steve Martino; Fiscal Year: 2005
    ..abstract_text> ..
  5. Economic Evaluation of Adolescent Drug Services
    Howard Liddle; Fiscal Year: 2003
    ..In accord with recommended strategies for economic evaluation studies of health care interventions, we propose to examine outcomes from two important perspectives: 1) societal and 2) state policy makers. ..
  6. CENTER FOR TREATMENT RESEARCH ON ADOLESCENT DRUG ABUSE
    Howard Liddle; Fiscal Year: 2003
    ..This collaboration has yielded an integrative perspective on core challenges to the field which we have formed into this proposal. ..
  7. Training Clinicians in Empirically Based Family Therapy
    Howard Liddle; Fiscal Year: 2006
    DESCRIPTION (provided by applicant): Emerging technology transfer research in drug abuse treatment and related fields suggests that the adoption of empirically supported treatments in community programs may be greatly facilitated with ..
  8. Computer Assisted System for Patient Assessment/Referral
    Deni Carise; Fiscal Year: 2008
    ..There are two parts to the technology transfer: a computer-assisted ASI assessment to improve the identification and prioritization of patients' ..
  9. Type 1 Diabetes Genetics Consortium
    Stephen Rich; Fiscal Year: 2007
    ..The Consortium will gain a better understandingof disease mechanisms, with a purpose of altering these mechanisms and pathways in individualsat risk of type 1 diabetes. ..
  10. Reducing Harm to Patients from Diagnostic Errors
    ETA BERNER; Fiscal Year: 2007
    ..To leverage AHRQ funding, additional support will be provided by registration fees, vendors, non-profit organizations and in-kind logistic support from the Society for Medical Decision Making. [unreadable] [unreadable] [unreadable]..
  11. Optical Coherence Tomography for Pulmonary Circulation
    Mark Brezinski; Fiscal Year: 2005
    ..Development of an OCT Imaging Catheter, Aim 2. Assessing the Pulmonary Veins Ablation in an Animal Model, Aim 3. Vascular Assessments In Vitro, Aim 4. OCT Elastography and Aim 5. OCT Imaging will be performed in an Animal Model of PTN. ..
  12. Optical Coherence Tomography for Microsurgical Guidance
    Mark Brezinski; Fiscal Year: 2005
    ..Use structural, polarization, and spectroscopic data to identify sensor vs motor nerves, and 7. guide epineural nerve repair with OCT guidance. ..
  13. HIV Risk Reduction for Women with Incarcerated Partners
    Olga Grinstead; Fiscal Year: 2005
    ..abstract_text> ..
  14. FLEX TM microPET/SPECT/CT to Support Cancer Research at Harvard Medical School
    JOHN FRANGIONI; Fiscal Year: 2006
    ..unreadable] [unreadable] [unreadable]..
  15. Psychotherapy Enhancement for TC Retention
    Samuel Ball; Fiscal Year: 2004
    ....
  16. Adapting a Medical Self-Management Program for a Community Mental Health Center
    Benjamin Druss; Fiscal Year: 2008
    ..If successful, it will provide a sustainable, scalable model for improving medical self-management in a highly vulnerable population. ..
  17. Development and Evaluation of Context Tailored Training
    JOHN BAER; Fiscal Year: 2006
    ..Based on concepts of technology transfer, change in practice behavior is seen as more likely in response to training that is tailored to the ..
  18. A Phase 1 Study of CCI-779 in Combination with Imatnib *
    RANDALL HOLCOMBE; Fiscal Year: 2006
    ..Since deregulated kinase activity is known to contribute to a wide range of malignancies, these studies will have applicability to cancer therapy in general. [unreadable] [unreadable]..
  19. TRANSFERRING DRUG ABUSE TREATMENT AND ASSESSMENT RESOURC
    D Simpson; Fiscal Year: 2008
    ..abstract_text> ..
  20. ALIGNMENT BASED METHODS FOR MOLECULAR SEQUENCE ANALYSIS
    Steven Henikoff; Fiscal Year: 2001
    ..This effort could yield new eukaryotic family members of great importance for understanding epigenetic phenomena, some of which, such as parental imprinting, are relevant to human disease. ..
  21. CNS METABOLIC CORRELATES OF HIV DEMENTIA BY MRS IMAGING
    Martin Pomper; Fiscal Year: 2001
    ..abstract_text> ..
  22. CANCER AND LEUKEMIA GROUP B--PET COMMITTEE
    Mark Ratain; Fiscal Year: 2002
    ..Since many of the studies include analysis of pharmacological specimens, the Committee utilizes three core laboratories--at the University of Chicago, the University of Maryland and the University of Tennessee. ..
  23. Hip Fracture Evaluation Alternatives of Total Hip vs Hemi-arthroplasty (HEALTH)
    Thomas Einhorn; Fiscal Year: 2009
    ..Potential Impact: This trial will not only change current orthopaedic practice, but will set a benchmark for the conduct of future orthopaedic trials. ..
  24. DEPRESSIVE DISORDERS IN PRIMARY CARE AND WORK SETTINGS
    Benjamin Druss; Fiscal Year: 2003
    ..This project will compare the impact of depression and three chronic medical illnesses on health costs, absenteeism and job performance ratings both cross-sectionally and over time. ..
  25. Objective Flap Assessment During Reconstructive Surgery
    JOHN FRANGIONI; Fiscal Year: 2009
    ..With the completion of these studies, we foresee being able to solve major clinical problems in reconstructive surgery using real-time, intraoperative objective assessment. ..
  26. HEALTH RELATED INTERVENTIONS FOR PERSONS LIVING WITH HIV
    MARY ROTHERAM BORUS; Fiscal Year: 2004
    ..abstract_text> ..
  27. Acquisition of an electrospray TOF mass spectrometer
    IGOR KALTASHOV; Fiscal Year: 2004
    ..The operation of the instrument will be overseen by a Mass Spectrometry Advisory committee comprised of faculty members representing three academic departments and one interdisciplinary research center at UMass. ..
  28. Client and Counselor Attitudes Toward Medication
    Dennis McCarty; Fiscal Year: 2003
    ..Aim 4. Test the impact of persuasion messages on medication usage attitudes, beliefs, normative beliefs, and attentions among both clients and counselors. ..
  29. GENOMIC ANALYSIS OF STRESS AND INFLAMMATION
    MASON FREEMAN; Fiscal Year: 2004
    ..abstract_text> ..
  30. A Depth-resolved Voltage Sensitive Dye Imaging System
    Elizabeth Hillman; Fiscal Year: 2007
    ..The effects of abnormal pathologies on neurovascular coupling could provide new insights for treatment and prevention. The new system could also find applications in ocular, dermal, endoscopic and tumor imaging. [unreadable] [unreadable]..
  31. Advanced Techniques for Assessing Osteoarthritis in Rats
    Mark Brezinski; Fiscal Year: 2008
    ..3. Examining the Combination of OCT with the Microawl Therapeutic Technique in a Surgical Rat Model of OA. 4. Examining the Combination of OCT with a Pharmaceutical Intervention in Surgical Rat Model of OA. ..
  32. Molecular Mechanisms of Skeletal Repair
    Thomas Einhorn; Fiscal Year: 2008
    ..Successful establishment and implementation of this program will greatly enhance the coordinated activities of this team of investigators and lead to important new results and directions for skeletal healing research. ..
  33. Mentor Mothers: A Sustainable Family Intervention in South African Townships
    Mary J Rotheram Borus; Fiscal Year: 2010
    ..The intervention's impact will be assessed over 15 months in a design that is a blend of an efficacy and effectiveness trial. ..
  34. Training Drug Treatment Providers to Adopt Evidence-Based Practices
    DANIEL SQUIRES; Fiscal Year: 2008
    ..provided by applicant): This project will evaluate a dissemination model developed by the Addiction Technology Transfer Center of New England (ATTCNE) to promote the adoption and utilization of evidence-based treatments for ..
  35. Phenotype and Gene Expression in Odontogenic Tumors
    JOHN T WRIGHT; Fiscal Year: 2010
    ..Gene data will be placed on our web site in a timely fashion for data sharing. These studies will provide the first detailed mutational and gene profile studies of human odontogenic tumors. ..
  36. Adoption of Buprenorphine in an HMO Setting
    Dennis McCarty; Fiscal Year: 2009
    ..Aim 3: Identify factors that facilitate and inhibit the adoption and use of buprenorphine through interviews with 530 patients and 96 practitioners and administrators. ..
  37. PSMA-based PET Ligands for Prostate Cancer Imaging
    Martin Pomper; Fiscal Year: 2007
    ..unreadable] [unreadable] [unreadable]..
  38. PSMA-based SPECT Tracers for Prostate Cancer Imaging
    Martin Pomper; Fiscal Year: 2007
    ..unreadable] [unreadable]..
  39. IMPROVING THE DIAGNOSTIC POTENTIAL OF OCT FOR VULNERABLE
    Mark Brezinski; Fiscal Year: 2002
    ..abstract_text> ..
  40. MOLECULAR IMAGING OF ADVANCED BLADDER CANCER
    JOHN FRANGIONI; Fiscal Year: 2002
    ..We believe that bladder cancer-specific, low-molecular weight ligands will someday be clinically useful reagents for improved detection and guided therapy of transitional cell carcinoma of the bladder. ..
  41. INTERVENTIONS FOR SUBSTANCE USING YOUTH LIVING WITH HIV
    MARY ROTHERAM BORUS; Fiscal Year: 2002
    ....
  42. Wnt Signaling in IBD-Related Colon Cancer
    RANDALL HOLCOMBE; Fiscal Year: 2005
    ..The precise effects of FIPs on Wnt signaling will be defined in vitro, with attention to the potentially disparate responses of different, specific, Fz receptor subtypes. ..
  43. Integration Difusion for SMI Service Delivery
    KIMBERLEY ISETT; Fiscal Year: 2005
    ..Analysis will be completed using repeated measures regression techniques. ..
  44. First International Biocurator Meeting
    Seung Rhee; Fiscal Year: 2006
    ..unreadable] [unreadable] [unreadable]..
  45. Near-Infrared Quantum Dots for In Vivo Imaging
    JOHN FRANGIONI; Fiscal Year: 2006
    ..If completed, the specific aims of this proposal will generate a clinically useful set of contrast agents, and a more complete understanding of the in vivo behavior of fluorescent semiconductor nanocrystals. [unreadable] [unreadable]..
  46. Targeted Social Network HIV Prevention Intervention
    Yuri Amirkhanian; Fiscal Year: 2007
    ..This research, if successful, will provide a model that can be used to focus HIV prevention efforts on community population segments in greatest need. ..
  47. MODIFYING GENE DETERMINANTS OF TOOTH AND BONE PHENOTYPES
    John Wright; Fiscal Year: 2007
    ..abstract_text> ..
  48. Maintenance of blocks-based tools for functional genomic
    Steven Henikoff; Fiscal Year: 2006
    ..These various components will be packaged to facilitate updates and local implementations. [unreadable] [unreadable]..
  49. MOTHERS LIVING WITH HIV AND THEIR ADOLESCENT CHILDREN
    MARY ROTHERAM BORUS; Fiscal Year: 2007
    ..abstract_text> ..
  50. NEUROTOXICITY OF METHYLMERCURY ACROSS THE LIFESPAN
    M Newland; Fiscal Year: 2005
    ..Items 2-4 will be conducted as adults and 3-4 to 30 months of age. At death Hg and either Se or FA profiles will be determined, depending on the cohort. ..
  51. Enhancement of informed consent in dental clinical trial
    J Goodson; Fiscal Year: 2003
    ..abstract_text> ..
  52. I-Talk: Eye Controlled, Direct Selection AAC Device
    GREGORY LESHER; Fiscal Year: 2002
    ..abstract_text> ..
  53. Mechanism & Efficacy of Assessing Osteoarthritis by OCT
    Mark Brezinski; Fiscal Year: 2009
    ..5. In patients undergoing microfracture during arthroscopy for the treatment of localized OA, OCT imaging will be performed of adjacent articular cartilage. ..
  54. Understanding Disability Among The Elderly
    David Cutler; Fiscal Year: 2005
    ....
  55. PSMA-based Gene Reporter-Probe System(RMI)
    Martin Pomper; Fiscal Year: 2008
    ..unreadable] [unreadable]..
  56. Organizational Change to Improve Access and Retention
    Dennis McCarty; Fiscal Year: 2009
    ..abstract_text> ..
  57. Identification and Treatment Of Unstable Plaque with OCT
    Mark Brezinski; Fiscal Year: 2009
    ..In addition, we will in parallel attempt to further improve the rabbit hemorrhagic plaque model by inducing angiogenesis, the factor which may ultimately be the trigger of many plaque ruptures. ..
  58. A Pilot Survey to Measure Disability in the Elderly Population
    David Cutler; Fiscal Year: 2006
    ..This research is critical for researchers, and for policy-makers who seek to understand why disability is changing and what implications those changes will have for longevity and medical spending. ..
  59. The role of copy number variants (CNV) in type 1 diabetes
    Stephen Rich; Fiscal Year: 2009
    ..Identification of genetic risk factors for T1D is the first step in risk prediction, intervention and developing disease therapeutics (prevention). ..
  60. LOW-MOLECULAR WEIGHT LIGANDS FOR PROSTATE CANCER
    JOHN FRANGIONI; Fiscal Year: 2003
    ..We believe that prostate- specific, low-molecular weight ligands will someday be clinically useful reagents for improved prostate cancer detection and guided therapy. ..